HSD17B13 and Hepatic fibrosis: Carriers of rs7261357:TA, a gene variant of Hydroxysteroid 17‐Beta Dehydrogenase 13 (HSD17B13), have been shown to correlate with decreased hepatic fibrosis and downregulation of the expression of inflammatory gene expression.75